世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028497

ウイルスベクター&プラスミドDNA製造市場レポート2021−2031

Visiongain

Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

発刊日 2020/11/24

言語英語

体裁PDF/586ページ

「PDF」版586ページ

0000028497

ウイルスベクター&プラスミドDNA製造市場レポート2021−2031
Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

3,999 GBP

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ベクターの種類別予測(アデノウイルス、レトロウイルス、プラスミドDNA、AAV、レンチウイルス、その他)、用途別(アンチセンス&RNAi、遺伝子治療、細胞療法、ワクチン学)、疾患別(オンコロジー、遺伝子疾患、感染症、その他)、エンドユーザー別(医薬品&バイオ医薬品メーカー、研究機関)、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東&アフリカ)、プラス、主要なウイルスベクター&プラスミドDNA製造企業、COVID-19の回復シナリオ

細胞および遺伝子治療のウイルスベクターにとってどのような規制上の問題があるのでしょうか。

ウイルスベクターの処理は複雑です。その一つは、学術研究の側から導入されたレガシー技術をスケールアップすることは困難です。技術的な課題と共に、優れた人材の不足も容量拡大の更なる障壁になります。比較的若い細胞や遺伝子治療の需要は世界的に極めて断片的です。ウイルスベクターの需要と不足を捕捉するための商業規模のCMO/CROはごく一部に限られます。商業規模で製造することが可能な企業はほんの一握りしかなく、自社の能力を高めることが可能なソリューションはほとんどありません。

ウイルスベクターの製造においては技術的にどのような進歩がありますか。

この初期成長段階においては遺伝子治療は非常に多くのコストがかかりますが、それはシングルフェーズで治癒することを約束するため、総医療費は低減されます。疾患を引き起こす遺伝子の発見における最近の進歩や遺伝子改変のための遺伝子編集技術の使用によって、多くの疾患の治療が可能になっています。その結果、バイオ医薬品メーカーは製品の迅速な市場展開に力を注いでいます。その例として、製造施設やサプライチェーンを世界的な患者の需要増大に見合った設計にすること、製造コストの削減、これらの新たなモダリティの効果と有効性、遺伝子治療薬の副作用を減らすことによって患者の安全性を高めることなどがあります。

レポート詳細

目次

1. Report Overview
1.1 Introduction to Viral Vectors and Plasmid DNA Manufacturing Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2 Executive Summary

3 Industry Insights
3.1 Drivers
3.1.1 Robust Pipeline for Gene Therapy and Viral Vectors
3.1.2 Increasing Capacities by Manufacturers Owing to Rising Demand
3.2 Restraints
3.2.1 High Cost of Therapies
3.2.2 Bottlenecks Experienced by Manufacturers
3.3 Opportunities
3.3.1 Rise in the Development of Allogenic and Autologous Cell Therapy
3.3.2 Lucrative opportunity in manufacturing of COVID-19 vaccine
3.3.3 Increasing Applications As Preclinical Tool In Neuroscience Research
3.4 Strategies to Overcome Challenges
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 SWOT Analysis
3.6.1 Strengths
3.6.2 Weaknesses
3.6.3 Opportunities
3.6.4 Threats

4 Viral Vector Production Capacity Mapping Analysis
4.1 CMOs Capacity for Viral Vector Manufacturing
4.2 Cleanroom Suites Facilities: Leading Viral Vector Manufacturers

5 Viral Vector Production & Yield Analysis
5.1 Introduction
5.2 ATMP Vectors and Manufacturing Platforms
5.3 Regulatory Challenges for Viral Vectors for Cell and Gene Therapy

6 Viral Vector Manufacturing: Process Economic Considerations and Challenges
6.1 Technological Advances in Manufacturing
6.2 Stable Producer Cell Lines
6.3 Addressing the Challenges of Cytotoxicity with Stable Producer Lines
6.4 What are the Process Development Considerations for the Use of Stable Producer Lines?
6.5 How Do Stable Producer Cell Lines Create Efficiencies and Reduce Costs in the Production of CGTs?
6.5.1 Simplified Upstream Production
6.5.2 Lower Costs for Reagents and Labour
6.5.3 More Flexibility for Scale Up
6.6 When is the Time to Switch from Transient Transfection to Stable Producer Cell Lines for LVV Manufacturing?
6.7 Cost Considerations
6.8 Regulatory Expectations

7 Viral Vectors Production Process Analysis
7.1 Introduction
7.2 Upstream Unit Operations (Cell Thaw and Expansion Through Transfection)
7.3 Downstream Unit Operations (Harvest Through Purification)
7.4 Formulation/Stability and Fill/Finish
7.5 Viral Analytics
7.6 Viral Vector Production: Facilities Needs
7.7 Regulatory Standard Needs
7.8 Workforce Development and Needs

8 Viral Vectors and Plasmid DNA Manufacturing Market by Vector Types
8.1 Adenovirus Segment Market Forecast, 2021-2031
8.1.1 Introduction
8.1.2 Adenoviruses are Promising Vaccine Adjuvant
8.1.3 Recovery Scenarios (V, U, W, L)
8.2 Retrovirus Segment Market Forecast, 2021-2031
8.2.1 Introduction
8.2.2 Recovery Scenarios (V, U, W, L)
8.3 Plasmid DNA Segment Market Forecast, 2021-2031
8.3.1 Introduction
8.3.2 Recovery Scenarios (V, U, W, L)
8.4 AAV Segment Market Forecast, 2021-2031
8.4.1 Introduction
8.4.2 Recovery Scenarios (V, U, W, L)
8.5 Lentivirus Segment Market Forecast, 2021-2031
8.5.1 Introduction
8.5.2 Recovery Scenarios (V, U, W, L)
8.6 Others Segment Market Forecast, 2021-2031
8.6.1 Recovery Scenarios (V, U, W, L)

9 Viral Vectors and Plasmid DNA Manufacturing Market by Application
9.1 Antisense & RNAi Segment Market Forecast, 2021-2031
9.1.1 Introduction
9.1.2 Recovery Scenarios (V, U, W, L)
9.2 Gene Therapy Segment Market Forecast, 2021-2031
9.2.1 Introduction
9.2.2 Recovery Scenarios (V, U, W, L)
9.3 Cell Therapy Segment Market Forecast, 2021-2031
9.3.1 Introduction
9.3.2 Recovery Scenarios (V, U, W, L)
9.4 Vaccinology Segment Market Forecast, 2021-2031
9.4.1 Introduction
9.4.2 Recovery Scenarios (V, U, W, L)

10 Viral Vectors and Plasmid DNA Manufacturing Market by Disease
10.1 Oncology Segment Market Forecast, 2021-2031
10.1.1 Introduction
10.1.2 Recovery Scenarios (V, U, W, L)
10.2 Genetic Disorders Segment Market Forecast, 2021-2031
10.2.1 Introduction
10.2.2 Recovery Scenarios (V, U, W, L)
10.3 Infectious Diseases Segment Market Forecast, 2021-2031
10.3.1 Introduction
10.3.2 Recovery Scenarios (V, U, W, L)
10.4 Others Segment Market Forecast, 2021-2031
10.4.1 Recovery Scenarios (V, U, W, L)

11 Viral Vectors and Plasmid DNA Manufacturing Market by End-Use
11.1 Pharma and Biopharma Companies Segment Market Forecast, 2021-2031
11.1.1 Introduction
11.1.2 Recovery Scenarios (V, U, W, L)
11.2 Research Institutes Segment Market Forecast, 2021-2031
11.2.1 Introduction
11.2.2 Recovery Scenarios (V, U, W, L)

12 Regional and Leading National Viral Vectors and Plasmid DNA Manufacturing Market Forecasts 2021-2031
12.1 Global Viral Vectors and Plasmid DNA Manufacturing Market by Region Forecast 2021-2031
12.2 Recovery Scenarios (V, U, W, L)

13 North America Viral Vectors and Plasmid DNA Manufacturing Market
13.1 North America Viral Vectors and Plasmid DNA Manufacturing Market by Country Forecast 2021-2031
13.1.1 Recovery Scenarios (V, U, W, L)
13.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
13.2.1 Recovery Scenarios (V, U, W, L): North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
13.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
13.3.1 Recovery Scenarios (V, U, W, L): North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
13.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
13.4.1 Recovery Scenarios (V, U, W, L): North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
13.5 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
13.5.1 Recovery Scenarios (V, U, W, L): North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
13.6 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
13.6.1 Recovery Scenarios (V, U, W, L): U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
13.7 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
13.8 U.S. Viral Vectors and Plasmid DNA Manufacturing
13.9 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
13.10 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
13.11 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
13.12 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
13.12.1 Introduction
13.12.2 Recovery Scenarios (V, U, W, L): Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
13.13 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
13.14 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
13.15 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
13.16 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031

14 Europe Viral Vectors and Plasmid DNA Manufacturing Market
14.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market by Country Forecast 2021-2031
14.1.1 Recovery Scenarios (V, U, W, L)
14.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
14.2.1 Recovery Scenarios (V, U, W, L): Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
14.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
14.3.1 Recovery Scenarios (V, U, W, L): Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
14.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
14.4.1 Recovery Scenarios (V, U, W, L): Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
14.5 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
14.5.1 Recovery Scenarios (V, U, W, L): Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
14.6 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
14.6.1 Introduction
14.6.2 Recovery Scenarios (V, U, W, L): Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
14.7 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
14.8 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
14.9 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
14.10 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
14.11 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
14.11.1 Introduction
14.11.2 Future Capacity and Expansion in UK
14.11.3 Recovery Scenarios (V, U, W, L): UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
14.12 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
14.13 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
14.14 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
14.15 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
14.16 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
14.16.1 Recovery Scenarios (V, U, W, L): Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
14.17 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
14.18 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
14.19 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
14.20 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031

15 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market
15.1 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market by Country Forecast 2021-2031
15.1.1 Recovery Scenarios (V, U, W, L)
15.2 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
15.2.1 Recovery Scenarios (V, U, W, L): Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
15.3 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
15.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
15.4 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
15.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
15.5 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
15.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
15.6 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.6.1 Announcement of GenScript to Operate Plasmid Facility in China
15.6.2 Recovery Scenarios (V, U, W, L): China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.7 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
15.8 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
15.9 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
15.10 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
15.11 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.11.1 Japan is the Third Biggest Pharmaceutical Industry Globally
15.11.2 Recovery Scenarios (V, U, W, L): Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.12 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
15.13 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
15.14 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
15.15 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
15.16 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.16.1 India to Witness the Highest Growth Rate Owing to Rising Government Support Towards Biotech Sector
15.16.2 Recovery Scenarios (V, U, W, L): India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.17 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
15.18 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
15.19 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
15.20 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
15.21 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.21.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
15.22 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
15.23 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
15.24 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
15.25 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031

16 Latin America Viral Vectors and Plasmid DNA Manufacturing Market
16.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market by Country Forecast 2021-2031
16.1.1 Recovery Scenarios (V, U, W, L)
16.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
16.2.1 Recovery Scenarios (V, U, W, L): Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
16.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
16.3.1 Recovery Scenarios (V, U, W, L): Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
16.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
16.4.1 Recovery Scenarios (V, U, W, L): Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
16.5 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
16.5.1 Recovery Scenarios (V, U, W, L): Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
16.6 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
16.6.1 Brazil Became First Country in Latin America to Approve Commercialization of Gene Therapy Products
16.6.2 Recovery Scenarios (V, U, W, L): Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
16.7 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
16.8 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
16.9 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
16.10 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
16.11 Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
16.11.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
16.12 Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
16.13 Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
16.14 Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
16.15 Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031

17 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market
17.1 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market by Country Forecast 2021-2031
17.1.1 Recovery Scenarios (V, U, W, L)
17.2 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
17.2.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
17.3 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
17.3.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
17.4 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
17.4.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
17.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
17.5.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
17.6 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
17.6.1 South African Government Focussing to Strengthen Biotech Industry
17.6.2 Recovery Scenarios (V, U, W, L): South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
17.7 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
17.8 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
17.9 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
17.10 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031
17.11 Rest of Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
17.11.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031
17.12 Rest of Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Types, 2021-2031
17.13 Rest of Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031
17.14 Rest of Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031
17.15 Rest of Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031

18 Company Profiles
18.1 Merck KGaA
18.1.1 Company Snapshot, 2020
18.1.2 Company Overview
18.1.3 Financial Analysis, 2015-2019
18.1.4 Product Benchmarking
18.1.5 Recent Developments
18.2 Lonza
18.2.1 Company Snapshot, 2020
18.2.2 Company Overview
18.2.3 Financial Analysis, 2015-2019
18.2.4 Product Benchmarking
18.2.5 Recent Developments
18.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc
18.3.1 Company Snapshot, 2020
18.3.2 Company Overview
18.3.3 Financial Analysis, 2015-2019
18.3.4 Product Benchmarking
18.3.5 Recent Developments
18.4 Cobra Biologics Ltd.
18.4.1 Company Snapshot, 2020
18.4.2 Company Overview
18.4.3 Product Benchmarking
18.4.4 Recent Developments
18.5 Brammer Bio
18.5.1 Company Snapshot, 2020
18.5.2 Company Overview
18.5.3 Product Benchmarking
18.5.4 Recent Developments
18.6 Waisman Biomanufacturing
18.6.1 Company Snapshot, 2020
18.6.2 Company Overview
18.6.3 Product Benchmarking
18.7 Genezen
18.7.1 Company Snapshot, 2020
18.7.2 Company Overview
18.7.3 Product Benchmarking
18.7.4 Recent Developments
18.8 YPOSKESI
18.8.1 Company Snapshot, 2020
18.8.2 Company Overview
18.8.3 Product Benchmarking
18.8.4 Recent Developments
18.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
18.9.1 Company Snapshot, 2020
18.9.2 Company Overview
18.9.3 Product Benchmarking
18.9.4 Recent Developments
18.10 Novasep Holding S.A.S
18.10.1 Company Snapshot, 2020
18.10.2 Company Overview
18.10.3 Product Benchmarking
18.10.4 Recent Developments
18.11 ATVIO Biotech Ltd
18.11.1 Company Snapshot, 2020
18.11.2 Company Overview
18.11.3 Product Benchmarking
18.11.4 Recent Developments
18.12 Vigene Biosciences, Inc
18.12.1 Company Snapshot, 2020
18.12.2 Company Overview
18.12.3 Product Benchmarking
18.12.4 Recent Developments
18.13 Cytiva
18.13.1 Company Snapshot, 2020
18.13.2 Company Overview
18.13.3 Financial Analysis, 2015-2019
18.13.4 Recent Developments
18.14 CEVEC Pharmaceuticals GmbH
18.14.1 Company Snapshot, 2020
18.14.2 Company Overview
18.14.3 Product Benchmarking
18.14.4 Recent Developments
18.15 Batavia Biosciences B.V
18.15.1 Company Snapshot, 2020
18.15.2 Company Overview
18.15.3 Product Benchmarking
18.15.4 Recent Developments
18.16 Biovian Oy
18.16.1 Company Snapshot, 2020
18.16.2 Company Overview
18.16.3 Product Benchmarking
18.17 Wuxi AppTec Co., Ltd.
18.17.1 Company Snapshot, 2020
18.17.2 Company Overview
18.17.3 Product Benchmarking
18.17.4 Recent Developments
18.18 VGXI, Inc.
18.18.1 Company Snapshot, 2020
18.18.2 Company Overview
18.18.3 Product Benchmarking
18.19 Paragon Bioservices, Inc.
18.19.1 Company Snapshot, 2020
18.19.2 Company Overview
18.19.3 Product Benchmarking
18.19.4 Recent Developments
18.20 Miltenyi Biotec GmbH
18.20.1 Company Snapshot, 2020
18.20.2 Company Overview
18.21 SIRION Biotech GmbH
18.21.1 Company Snapshot, 2020
18.21.2 Company Overview
18.21.3 Product Benchmarking
18.22 Virovek Incorporation
18.22.1 Company Snapshot, 2020
18.22.2 Company Overview
18.22.3 Product Benchmarking
18.23 BioNTech IMFS GmbH
18.23.1 Company Snapshot, 2020
18.23.2 Company Overview
18.23.3 Product Benchmarking
18.24 VIVEbiotech S.L.
18.24.1 Company Snapshot, 2020
18.24.2 Company Overview
18.24.3 Product Benchmarking
18.24.4 Recent Developments
18.25 Creative Biogene
18.25.1 Company Snapshot, 2020
18.25.2 Company Overview
18.25.3 Product Benchmarking
18.25.4 Recent Developments
18.26 Vibalogics GmbH
18.26.1 Company Snapshot, 2020
18.26.2 Company Overview
18.26.3 Product Benchmarking
18.26.4 Recent Developments
18.27 Cell and Gene Therapy Catapult
18.27.1 Company Snapshot, 2020
18.27.2 Company Overview
18.28 BlueBird Bio
18.28.1 Company Snapshot, 2020
18.28.2 Company Overview
18.29 Addgene, Inc.
18.29.1 Company Snapshot, 2020
18.29.2 Company Overview
18.29.3 Product Benchmarking
18.29.4 Recent Developments
18.30 Aldevron, L.L.C.
18.30.1 Company Snapshot, 2020
18.30.2 Company Overview
18.30.3 Product Benchmarking
18.31 Audentes Therapeutics
18.31.1 Company Snapshot, 2020
18.31.2 Company Overview
18.31.3 Recent Developments
18.32 BioMarin Pharmaceutical
18.32.1 Company Snapshot, 2020
18.32.2 Company Overview
18.32.3 Financial Analysis, 2015-2019
18.32.4 Recent Developments

19 Conclusion
19.1 Concluding Remarks
19.2 Choosing a Cell Culture Technology
19.3 Increased Urgency In Addressing Manufacturing Challenges

List of Tables
Table 1 Global Viral Vectors and Plasmid DNA Manufacturing Market Snapshot, 2020 & 2031 (US$ million, CAGR %)
Table 2 Advantages and Disadvantages of Adeno-Associated Virus Vectors
Table 3 Key Factors Affecting the Bargaining Power of Buyer
Table 4 Key Factors Affecting the Bargaining Power of Suppliers
Table 5 Key Factors Affecting the Industry Rivalry
Table 6 Key Factors Affecting the Threat of Substitutes
Table 7 Key Factors Affecting the Threat of New Entrants
Table 8 CMOs Capacity for Viral Vector Manufacturing
Table 9 Cleanroom Suites Facilities
Table 1 Global Viral Vectors and Plasmid DNA Manufacturing Market for Adenovirus Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 2 Global Viral Vectors and Plasmid DNA Manufacturing Market for Adenovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Viral Vectors and Plasmid DNA Manufacturing Market for Adenovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Viral Vectors and Plasmid DNA Manufacturing Market for Adenovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Viral Vectors and Plasmid DNA Manufacturing Market for Adenovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Global Viral Vectors and Plasmid DNA Manufacturing Market for Retrovirus Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 7 Global Viral Vectors and Plasmid DNA Manufacturing Market for Retrovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 8 Global Viral Vectors and Plasmid DNA Manufacturing Market for Retrovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 9 Global Viral Vectors and Plasmid DNA Manufacturing Market for Retrovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 10 Global Viral Vectors and Plasmid DNA Manufacturing Market for Retrovirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 11 Global Viral Vectors and Plasmid DNA Manufacturing Market for Plasmid DNA Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 12 Global Viral Vectors and Plasmid DNA Manufacturing Market for Plasmid DNA Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 13 Global Viral Vectors and Plasmid DNA Manufacturing Market for Plasmid DNA Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 14 Global Viral Vectors and Plasmid DNA Manufacturing Market for Plasmid DNA Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 15 Global Viral Vectors and Plasmid DNA Manufacturing Market for Plasmid DNA Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 16 Global Viral Vectors and Plasmid DNA Manufacturing Market for AAV Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 17 Global Viral Vectors and Plasmid DNA Manufacturing Market for AAV Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 18 Global Viral Vectors and Plasmid DNA Manufacturing Market for AAV Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 19 Global Viral Vectors and Plasmid DNA Manufacturing Market for AAV Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 20 Global Viral Vectors and Plasmid DNA Manufacturing Market for AAV Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 21 Global Viral Vectors and Plasmid DNA Manufacturing Market for Lentivirus Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 22 Global Viral Vectors and Plasmid DNA Manufacturing Market for Lentivirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 23 Global Viral Vectors and Plasmid DNA Manufacturing Market for Lentivirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 24 Global Viral Vectors and Plasmid DNA Manufacturing Market for Lentivirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 25 Global Viral Vectors and Plasmid DNA Manufacturing Market for Lentivirus Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 26 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 27 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 32 Global Viral Vectors and Plasmid DNA Manufacturing Market for Antisense & RNAi Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 33 Global Viral Vectors and Plasmid DNA Manufacturing Market for Antisense & RNAi Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 34 Global Viral Vectors and Plasmid DNA Manufacturing Market for Antisense & RNAi Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 35 Global Viral Vectors and Plasmid DNA Manufacturing Market for Antisense & RNAi Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 36 Global Viral Vectors and Plasmid DNA Manufacturing Market for Antisense & RNAi Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 37 The current industry-wide gene therapy pipeline can be organized by stage and therapeutic area
Table 38 Global Viral Vectors and Plasmid DNA Manufacturing Market for Gene Therapy Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 39 Global Viral Vectors and Plasmid DNA Manufacturing Market for Gene Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 40 Global Viral Vectors and Plasmid DNA Manufacturing Market for Gene Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 41 Global Viral Vectors and Plasmid DNA Manufacturing Market for Gene Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 42 Global Viral Vectors and Plasmid DNA Manufacturing Market for Gene Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 43 List of Cell Therapy Companies Worldwide by Location and Type
Table 44 Global Viral Vectors and Plasmid DNA Manufacturing Market for Cell Therapy Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Global Viral Vectors and Plasmid DNA Manufacturing Market for Cell Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global Viral Vectors and Plasmid DNA Manufacturing Market for Cell Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global Viral Vectors and Plasmid DNA Manufacturing Market for Cell Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global Viral Vectors and Plasmid DNA Manufacturing Market for Cell Therapy Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Viral Vectors and Plasmid DNA Manufacturing Market for Vaccinology Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 50 Global Viral Vectors and Plasmid DNA Manufacturing Market for Vaccinology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Global Viral Vectors and Plasmid DNA Manufacturing Market for Vaccinology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Global Viral Vectors and Plasmid DNA Manufacturing Market for Vaccinology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Global Viral Vectors and Plasmid DNA Manufacturing Market for Vaccinology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 55 Global Viral Vectors and Plasmid DNA Manufacturing Market for Oncology Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 56 Global Viral Vectors and Plasmid DNA Manufacturing Market for Oncology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Viral Vectors and Plasmid DNA Manufacturing Market for Oncology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Viral Vectors and Plasmid DNA Manufacturing Market for Oncology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Viral Vectors and Plasmid DNA Manufacturing Market for Oncology Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 60 Global Viral Vectors and Plasmid DNA Manufacturing Market for Genetic Disorders Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 61 Global Viral Vectors and Plasmid DNA Manufacturing Market for Genetic Disorders Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Viral Vectors and Plasmid DNA Manufacturing Market for Genetic Disorders Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Viral Vectors and Plasmid DNA Manufacturing Market for Genetic Disorders Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Viral Vectors and Plasmid DNA Manufacturing Market for Genetic Disorders Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Viral Vectors and Plasmid DNA Manufacturing Market for Infectious Diseases Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 66 Global Viral Vectors and Plasmid DNA Manufacturing Market for Infectious Diseases Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Viral Vectors and Plasmid DNA Manufacturing Market for Infectious Diseases Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Viral Vectors and Plasmid DNA Manufacturing Market for Infectious Diseases Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Viral Vectors and Plasmid DNA Manufacturing Market for Infectious Diseases Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 71 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Viral Vectors and Plasmid DNA Manufacturing Market for Others Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 Global Viral Vectors and Plasmid DNA Manufacturing Market for Pharma & Biopharma Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 76 Global Viral Vectors and Plasmid DNA Manufacturing Market for Pharma & Biopharma Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 77 Global Viral Vectors and Plasmid DNA Manufacturing Market for Pharma & Biopharma Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 78 Global Viral Vectors and Plasmid DNA Manufacturing Market for Pharma & Biopharma Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 79 Global Viral Vectors and Plasmid DNA Manufacturing Market for Pharma & Biopharma Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 80 Global Viral Vectors and Plasmid DNA Manufacturing Market for Research Institutes Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 81 Global Viral Vectors and Plasmid DNA Manufacturing Market for Research Institutes Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 82 Global Viral Vectors and Plasmid DNA Manufacturing Market for Research Institutes Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 83 Global Viral Vectors and Plasmid DNA Manufacturing Market for Research Institutes Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 84 Global Viral Vectors and Plasmid DNA Manufacturing Market for Research Institutes Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 85 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 86 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 87 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 88 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 89 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 90 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 91 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 92 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 93 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 94 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 95 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 96 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 97 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 98 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 99 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 100 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 101 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 102 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 103 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 104 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 105 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 106 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 111 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 North America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 116 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 117 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 121 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 122 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 123 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 125 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 126 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 127 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 128 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 129 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 130 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 131 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 132 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 133 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 134 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 135 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 136 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 137 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 138 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 139 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 140 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 141 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 142 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 143 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 144 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 145 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 146 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 147 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 148 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 149 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 150 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 152 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 153 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 154 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 159 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 164 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 165 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 166 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 167 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 168 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 169 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 170 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 171 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 172 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 173 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 174 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 175 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 176 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 177 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 182 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 184 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 186 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 187 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 188 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 189 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 190 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 191 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 192 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 193 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 194 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 195 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 196 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 197 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 198 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 199 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 200 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 201 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 202 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 203 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 204 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 205 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 206 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 207 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 210 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 215 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 216 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 217 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 218 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 219 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 220 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 221 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 222 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 223 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 224 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 227 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 228 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 233 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 234 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 235 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 236 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 237 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 238 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 239 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 240 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 241 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Vector Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 242 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 243 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 244 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Forecast by End-Use, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 245 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 246 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 Latin America Vir

この商品のレポートナンバー

0000028497

TOP